DarioHealth Corp. (NASDAQ:DRIO)
| Market Cap | $14.90M-89.8% |
| Revenue (ttm) | $21.30M-13.9% |
| Net Income | $61.01M+279.8% |
| EPS | $5.41+115.6% |
| Shares Out | 11.29M |
| PE Ratio | 0.24 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,213 |
| Open | $1.35 |
| Previous Close | $1.44 |
| Day's Range | $1.26 - $1.65 |
| 52-Week Range | $1.09 - $14.49 |
| Beta | 1.18 |
| Analysts | Buy |
| Price Target | $6.00(+354.55%) |
| Earnings Date | Mar 18, 2027 |
About DRIO
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Mar 18, 2027Earnings report
$DRIO stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in DRIO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by DRIO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
DRIO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New DRIO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to DRIO from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in DRIO
| VXFVanguard Extended Market ETF | $232.03K |
| IWCiShares Micro-Cap ETF | $26.24K |
| DCORU.S. Core Equity 1 Portfolio ETF Class Shares | $1.73K |
| DFSUDimensional - US Sustainability Core 1 ETF | $1.08K |
| DFMCU.S. Micro Cap Portfolio ETF | $288 |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from DRIO’s recent data — informational, not investment advice
What’s Behind the Score
News check: Strong business momentum with strategic partnerships, revenue beat, and 48% consumer revenue growth outweigh a partial analyst price-target cut.
